Biomedcode has been and is a partner of choice in European and National Research Networks that aim at the study of disease mechanisms and the discovery of novel therapeutics focusing on topics such as Rheumatoid Arthritis, Inflammation, Cancer, Aging etc.

Our Participation in National and European Networks

BreastCaRANKL
2018-2021 A nationally funded collaborative research project aiming at the development of an innovative human-RANKL dependent breast cancer mouse model towards the development of novel preclinical platforms for the evaluation of human therapeutics targeting cancer.
HUPLA
2018-2021 A nationally funded collaborative research project aiming at the development of humanized platforms that will allow the evaluation of therapeutics targeting autoimmune pathologies.

2017-2020 A funding scheme supporting the development of a world-class research infrastructure that will provide enduring mouse resources and services towards advancing research into human health and disease.


2011-2015 An IMI (Innovative Medicines Initiative) funded research project aiming to develop new therapies against rheumatoid arthritis.

aDDRess

2012-2016 An FP7 Marie Curie ITN focusing on the study of chromatin dynamics and the DNA damage response also in pathologies such as intestinal inflammation and cancer.

2012-2016 An FP7 Marie Curie ITN focusing on the role of chronic DNA damage in ageing and age-related pathology including arthritis.

2011-2014 a National Network of Excellence collaborative project aiming to establish a drug pipeline towards the development of novel therapeutic lead compounds targeting arthritis

2012-2015 A collaborative research project aiming at targeting Src-family kinases for the treatment of chronic autoimmune and inflammatory disorders including arthritis.
2008-2013 A large scale integrating project focusing on the study of disease mechanisms with the aim to attack steering effectors of Rheumatoid Syndromes with innovative therapy choices.
2009-2012 A large scale integrating project focusing on the understanding of inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies.

2005-2009 FP6 Network of Excellence aiming towards integrated Functional Genomics in Mutant Mouse Models as Tools to Investigate the Complexity of Human Immunological Disease.